SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000333
Filing Date
2021-09-22
Accepted
2021-09-22 14:58:52
Documents
9
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kaug2021.htm 6-K 10788
2 EXHIBIT 99.1 nr_ex99z1.htm EX-99.1 15214
3 EXHIBIT 99.2 fs_ex99z2.htm EX-99.2 235879
4 EXHIBIT 99.3 mda_ex99z3.htm EX-99.3 109175
5 EXHIBIT 99.4 ceocert_ex99z4.htm EX-99.4 5997
6 EXHIBIT 99.5 cfocert_ex99z5.htm EX-99.5 6019
7 IMAGE nrex99z1_1.jpg GRAPHIC 7366
8 IMAGE fsex99z2_1.jpg GRAPHIC 13437
9 IMAGE mdaex99z3_1.jpg GRAPHIC 6822
  Complete submission text file 0001052918-21-000333.txt   422864
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211269403
SIC: 2834 Pharmaceutical Preparations